Characterization of a Tumor-Associated Activating Mutation of the P110β PI 3-Kinase

PLoS ONE - United States
doi 10.1371/journal.pone.0063833
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)

Related search

Phosphoinositide 3-Kinase, Catalytic, Β-Peptide (PIK3CB; PI3K- P110β; P110β)

Science-Business eXchange
2008English

Phosphoinositide 3-Kinase Mutations in Breast Cancer: A "Good" Activating Mutation?

Clinical Cancer Research
Cancer ResearchOncology
2009English

Essential Roles of PI(3)K–p110β in Cell Growth, Metabolism and Tumorigenesis

Nature
Multidisciplinary
2008English

Combining Genomic Analyses With Tumour-Derived Slice Cultures for the Characterization of an EGFR-activating Kinase Mutation in a Case of Glioblastoma

BMC Cancer
Cancer ResearchOncologyGenetics
2018English

PI 3-Kinase Inhibition: A Therapeutic Target for Respiratory Disease

Biochemical Society Transactions
Biochemistry
2004English

Critical Roles for the Phosphatidylinositide 3-Kinase Isoforms P110β and P110γ in Thrombopoietin-Mediated Priming of Platelet Function

Scientific Reports
Multidisciplinary
2019English

The P110δ Isoform of PI 3-Kinase Negatively Controls RhoA and PTEN

EMBO Journal
ImmunologyMolecular BiologyBiochemistryMicrobiology NeuroscienceMedicineGenetics
2007English

Characterization of Tumor-Associated Chk2 Mutations

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2000English

Active Site Mutation A126G Abrogates PI(4,5)P2-Mediated Allosteric Activation of the Tumor Suppressor PTEN

Biophysical Journal
Biophysics
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy